Novolog (Pharm-Up 1966) Ltd (TLV:NVLG)

Novolog (Pharm-Up 1966) Revenue

Novolog (Pharm-Up 1966) had revenue of 483.59M ILS in the quarter ending September 30, 2025, a decrease of -12.22%. This brings the company's revenue in the last twelve months to 1.97B, up 4.89% year-over-year. In the year 2024, Novolog (Pharm-Up 1966) had annual revenue of 2.02B with 23.01% growth.

• Revenue (ttm): 1.97B
• Revenue Growth: +4.89%
• P/S Ratio: 0.33
• Revenue / Employee: 2.11M
• Employees: 936
• Market Cap: 647.28M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.02B	378.11M	23.01%
Dec 31, 2023	1.64B	135.54M	8.99%
Dec 31, 2022	1.51B	252.70M	20.13%
Dec 31, 2021	1.26B	121.61M	10.73%
Dec 31, 2020	1.13B	129.51M	12.90%